willdate

44 POSTS 0 COMMENTS

Abbott receives CE mark approval for Gallant ICD and CRT-D devices

Abbott has announced that it has received CE mark approval for the Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy defibrillator (CRT-D) devices. The...

One in three patients treated in line with ICD guidelines

Decline in defibrillation testing during ICD implantation
A study of patients undergoing implantable cardioverter defibrillator (ICD) therapy across three centres, found that only one in three were treated in concordance with...

VitalConnect adds arrhythmia detection to its remote monitoring software

VitalConnect has announced the introduction of arrhythmia detection to its remote monitoring portfolio. In partnership with CorVitals, VitalConnect now offers physicians the ability to...

ACC partners with AED device company for cardiac arrest alliance

The American College of Cardiology (ACC) and automated external defibrillator (AED) technology start-up HeartHero have formed an alliance aimed at making a “significant impact”...

AI-guided cardiac imaging system given FDA authorisation

The US Food and Drug Administration (FDA) has authorised marketing of software to assist in the acquisition of cardiac ultrasound, or echocardiography, images. The...

CardioFocus submits HeartLight X3 PMA application to FDA

The HeartLight Excalibur Balloon used with the HeartLight X3 system
CardioFocus has submitted a pre-market approval (PMA) supplement to the US Food and Drug Administration (FDA) for the HeartLight X3 Endoscopic Ablation System for...

Value of augmented reality goes well beyond holograms in the electrophysiology...

 Jennifer Silva (St Louis, USA) talks to BLearning Cardio at SIR 2019 (Society of Interventional Radiology; 23–28 March; Austin, USA) about why physicians should...

Medtronic receives CE Mark for Cobalt and Crome implantable ICDs

Medtronic has received CE Mark for its Cobalt and Crome portfolio of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronisation therapy-defibrillators (CRT-D). ICDs monitor heart rhythms...

Eko receives FDA clearance for AF and heart murmur algorithms

Eko has announced that the US Food and Drug Administration (FDA) has cleared a suite of algorithms that, when combined with Eko’s digital stethoscopes,...

AF Symposium 2020: Acutus Medical live streams case using AcQMap System

Acutus Medical offered a demonstration of its AcQMap advanced cardiac imaging and mapping system at AF Symposium (23–25 January, Washington, DC, USA) with a live-stream...

Medtronic gains FDA approval for PulseSelect trial

Medtronic has received approval from the US Food and Drug Administration (FDA) to proceed with an investigational device exemption (IDE) trial to evaluate the...

BardyDx announces commercial launch of the 14-day CAM Patch

Bardy Diagnostics (BardyDx) has today announced the commercial launch of the 14-Day version of the Carnation Ambulatory Monitor (CAM), the P-wave centric ambulatory cardiac...

Biotronik announces Japanese launch of injectable cardiac monitor

biomonitor
Biotronik has announced the market release of its injectable cardiac monitor (ICM), BioMonitor III in Japan. The device is designed to help patients with...

Hypocapnia could aid ablation of cardiac arrhythmias

A technique that enables patients suffering from heart conditions to hold their breath safely for over five minutes could have potential as a treatment...

AI and its growing role in arrhythmia

Malcom Finlay (Bart's Health Centre, London, UK) reviews the growing role of artificial intelligence (AI) in diagnosing arrhythmias.  Johnny, a 72-year-old film producer, is meeting...

Medtronic receives FDA approval for Micra AV

Medtronic has announced that it has received US Food and Drug Administration (FDA) approval of Micra AV, the world’s smallest pacemaker with atrioventricular (AV)...

CardioFocus appoints Burke T Barrett as chief executive

CardioFocus, has announced that the company’s board of directors has promoted Burke T Barrett to the position of chief executive officer (CEO), effective January...

First patient enrolled in PREDICT-LAA clinical trial

FEops has announced that the first patient has been enrolled in the physician-initiated PREDICT-LAA trial. The trial is led by Righshospitalet (Copenhagen, Denmark) and aims...

Cardiac Rhythm News Issue 47 – January 2020

Cardiac Rhythm News Issue 47
Highlights: WRAP-IT shows significant mortality risk with CIED infection, and reduced quality of life Sequential approach using STAR mapping system identifies key early sites...

Leading electrophysiologists identify four key studies that will shape arrhythmia treatment...

Leading electrophysiologists have pinpointed four clinical studies due to report findings in 2020—AMULET IDE, aMAZE IDE, PULSED AF and CEASE AF—that they expect to...

Persistent atrial fibrillation—seeking the sources of the cardiac electrical field

Andrew Grace charts the evolution of non-contact mapping culminating in the current AcQMap system—the technology has advanced understanding of persistent atrial fibrillation (AF), providing...

Eric N Prystowsky

Eric Prystowsky
Eric N Prystowsky (director of the Cardiac Arrhythmia Service at St Vincent Hospital, Indianapolis, and a consulting professor of medicine at Duke University Medical...

NICE recommends use of Reveal LINQ implantable cardiac monitor

The UK National Institute for Health and Care Excellence (NICE) has issued draft guidance recommending the use of the Reveal LINQ (Medtronic) implantable cardiac...

Ed Vertatschitsch joins Bardy Diagnostics as chief operating officer

Bardy Diagnostics (BardyDx) has announced today the appointment of Ed Vertatschitsch as chief operating officer. Effective 2 January 2020, the appointment will see Vertatschitsch...

ACC makes senior staff appointments

American College of Cardiology makes senior staff appointments
The American College of Cardiology (ACC) has announced several promotions and structural changes within its senior staff. The College said that the staff changes...

Stryker launches voluntary field action for LIFEPAK 15

Stryker
Stryker has launched a voluntary field action on specific units of the LIFEPAK 15 monitor and defibrillator. In an announcement issued by the company on...

AtriCure announces completion of enrolment for aMAZE clinical trial

  AtriCure has announced the successful completion of patient enrolment in the aMAZE clinical trial. In addition, the company announced that it has received approval...

FDA grants Breakthrough designation for ECG-based algorithm

ECG based algorithm
The US Food and Drug Administration has granted Breakthrough Device designation to the digital health and artificial intelligence (AI) company Eko for an echocardiogram...

European trial data ‘reinforce’ safety profile and efficacy of Lixiana

European Trial Data
Daiichi Sankyo Europe has announced outcomes from an observational study in mainly caucasian atrial fibrillation (AF) patients being treated with the anti-coagulation drug edoxaban...

First patients treated in robotic arrhythmia care programme at Overland Park...

Dhanunjaya Lakkireddy performs the first robotic cardiac ablation procedure at OPRMC
Stereotaxis announced today that HCA Midwest Health has launched a new robotic arrhythmia care programme based at Overland Park Regional Medical Center (OPRMC). Installation...

FDA panel votes against approval of AF drug Brinavess

Cardiac Rhythm news for specialists
The US Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has voted not to recommend approval for the anti-arrhythmic drug...

Impulse Dynamics secures funding to commercialise Optimizer Smart

Impulse Dynamics has announced the completion of a US$80.25 million Series D financing round with new investors. Proceeds will be used primarily to facilitate...

Tackling focal VT may improve catheter ablation in structural heart disease

Uncovering and abolishing focal ventricular tachycardia (VT) may further improve outcomes of catheter ablation in the treatment of structural heart disease, a study published...

VivaLnk’s multi-vital wearable sensor and software development kit receive CE mark

VivaLnk has announced it has received the class IIa medical device CE mark for its multi-vital medical wearable sensor and software development kit (SDK). The...

PADIT score predicts CIED infection risk

Five independent predictors of cardiac implantable electronic device (CIED) infection have been identified which could be used to aid physicians and patients in decision-making...

Pedro Brugada

With his brothers Josep and Ramon, Pedro Brugada discovered the syndrome that bears their name. He reflects on his career highlights with Cardiac Rhythm...

AHA 2019: Correvio announces new data from SPECTRUM Brinavess study

Cardiac Rhythm news for specialists
Correvio announced the presentation of new data from the SPECTRUM study evaluating Brinavess (vernakalant hydrochloride, IV), an antiarrhythmic drug for the rapid conversion of...

Cardiac Rhythm News Issue 46 – October 2019

Highlights: ESC guidelines on supraventricular tachycardias underline the pivotal role of catheter ablation therapy Study suggests increased use of DOACs in AF leads to...

Left atrial appendage closure associated with a decreased stroke risk in...

Left atrial appendage closure (LAAC) via implanted device was associated with a decreased risk of admission for stroke, compared with the expected risk without...

First patients treated using integrated navigation technology from Stereotaxis and ADAS...

Stereotaxis and ADAS 3D Medical have announced that the first patients have been treated with the integration of ADAS 3D’s advanced preoperative substrate mapping...

CardioFocus treats first patients with HeartLight endoscopic ablation system in France

The HeartLight Excalibur Balloon used with the HeartLight X3 system
CardioFocus has announced that the first patients in France have been treated in the University Public Hospital of Nancy with the HeartLight endoscopic ablation...

Cardiva Medical announces publication of data from AMBULATE pivotal study

Cardiva Medical has said that results from the AMBULATE pivotal study demonstrate the safety and efficacy of its VASCADE MVP venous vascular closure system...

Bardy Diagnostics wins digital health pitch session at ESC Congress

Bardy Diagnostics announced that it was selected as winner of the ‘Remote Monitoring in Arrhythmias’ Technology and Innovation Pitch Session held as part of...

Low bleeding and cardiovascular events in elderly NVAF patients using edoxaban,...

Cardiac Rhythm news for specialists
Daiichi Sankyo has announced one-year follow-up results from an analysis of 12,574 European non-valvular atrial fibrillation (NVAF) patients, mostly elderly, treated with edoxaban (Lixiana)....